Back to results
US 7,115,371 B2Granted
Rapid, sensitive and quantitative methods for tissue and cell-based proteomics via consecutive addition of quantifiable extenders
AssigneeThe Trustees of the University of Pennsylvania
InventorJames Eberwine
Life of this patent
Estimating the term…
Abstract
Methods, systems and kits are provided for detecting and quantifying multiple immunogens in a sample via consecutive addition of quantifiable extenders to immunogen bound complexes of immunogen binding agent attached to a DNA containing an RNA polymerase promoter.
Claims1
A method for detecting and quantifying multiple immunogens in a sample comprising:
- (a) forming an immunogen-binding agent-DNA complex extended with two oligonucleotides, oligo 1 and oligo 2, by:
- (i) contacting an immobilized form of immunogens with an epitope detector comprising an immunogen-binding agent-DNA complex, wherein the DNA of the complex contains an RNA polymerase promoter;
- (ii) incubating the immobilized form of immunogens and the epitope detector under conditions which promote binding of the first immunogen-binding agent-DNA complex to an immunogen;
- (iii) ligating oligo 1 to the bound first immunogen-binding agent-DNA complex to form a complex immunogen-binding agent-DNA-oligo 1;
- (iv) ligating oligo 2 to the bound immunogen-binding agent-DNA-oligo 1 complex to form immunogen-binding agent-DNA-oligo 1-oligo 2;
- (b) repeating step (a) with different epitope detectors comprising Immunogen-binding-agents for different immunogens in the sample;
- (C) removing all bound immunogen-binding agent-DNA-oligo complexes from the immobilized immunogens;
- (d) adding RNA polymerase to the immunogen-binding agent-DNA-oligo complexes to form RNA products;
- and
- (e) analyzing RNA products wherein an amount of RNA product is directly proportional to the amount of immunogen-binding agent-DNA-oligo complexes bound to the immobilized immunogens in step (a) and size of an RNA product corresponds to the step at which the immunogen-binding agent was added with earlier added immunogen-binding agents giving rise to longer products while later added immunogen-binding agents produce smaller products.
7 more elements
Dependencies are inferred from the claim text.